Trial site
Synexus Polska Sp. z o.o.
- 21running trials
- 18closed trials
The trials here
What the 39 trials at this site are about, from their registry records.
- Conditions
- Atopic dermatitis (eczema)8 trials
- Obesity5 trials
- Fatty liver disease (MASLD/MASH)4 trials
- Psoriasis4 trials
- Crohn's disease3 trials
- Osteoporosis3 trials
- Type 2 diabetes3 trials
- Asthma2 trials
- Chronic kidney disease2 trials
- Lupus (SLE)2 trials
- Vitiligo2 trials
- COPD1 trial
- and 5 more
- Phase
- Phase 326 trials
- Phase 212 trials
- Phase 2/31 trial
- Status
- Completed18 trials
- Active, not recruiting14 trials
- Recruiting6 trials
- Not yet recruiting1 trial
- Lead sponsor
- Pfizer4 trials
- Akero Therapeutics Inc.2 trials
- Alumis Inc2 trials
- Ascletis Pharma (China) Co. Ltd.2 trials
- AstraZeneca2 trials
- and 25 more
Running trials
Recruiting
Recruiting
Not yet recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Efficacy and Safety of MET097 Once-Weekly in People With Overweight or Obesity
Active, not recruiting
A Study of KT-621 Administered Orally to Participants With Moderate to Severe Atopic Dermatitis
Recruiting
Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib
Recruiting
Active, not recruiting
Long-term Safety and Efficacy of ESK-001 in Moderate to Severe Plaque Psoriasis
Recruiting
Recruiting
A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Fatty liver disease (MASLD/MASH)2 recruiting
- Obesity2 recruiting
- Atopic dermatitis (eczema)1 recruiting
- Hidradenitis suppurativa1 recruiting
- Type 2 diabetes1 recruiting
- Vitiligo1 recruiting
Closed trials
Completed
Completed
Completed
Completed
A Study of LY4100511 (DC-853) in Adult Participants With Moderate-to-Severe Plaque Psoriasis
Completed
Completed
Efficacy, safety, PK, PD, and immunogenicity of BP16 in post-menopausal osteoporosis
Completed
Completed
Completed
Completed
A Study to Evaluate Astegolimab in Participants With Chronic Obstructive Pulmonary Disease
Completed
Safety Study of CC-93538 in Adult and Adolescent Participants With Eosinophilic Esophagitis
Completed
Study to Assess the Efficacy and Safety of Atuliflapon in Moderate-to-Severe Uncontrolled Asthma
Completed
Completed
Long-term Safety and Efficacy of Nemolizumab With Moderate-to-severe Atopic Dermatitis
Completed
Completed
Completed
Completed
Site data: EU CTIS (euclinicaltrials.eu)Updated 17 Nov 2026